Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2389902 | 0.98 | TLR7 (0.63) | TLR7IL6 | |
| SCHEMBL1244771 | 0.98 | TLR7 (0.65) | TLR7IL6 | |
| SCHEMBL1244962 | 0.97 | TLR7 (0.65) | TLR7IL6 | |
| SCHEMBL2843218 | 0.90 | TLR7 (0.65) | TLR7IL6 | |
| SCHEMBL1244619 | 0.89 | TLR7 (0.62) | TLR7 | |
| SCHEMBL2389795 | 0.88 | TLR7 (0.66) | TLR7IL6 | |
| SCHEMBL2837664 | 0.88 | TLR7 (0.68) | TLR7IL6 | |
| SCHEMBL2389070 | 0.88 | TLR7 (0.63) | TLR7IL6 | |
| SCHEMBL12048706 | 0.88 | TLR7 (0.65) | TLR7 | |
| Bromide SCHEMBL3363812 | 0.87 | TLR7 (0.67) | TLR7IL6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1728793-B1 | 9-SUBSTITUTED 8-OXOADENINE COMPOUND | SUMITOMO DAINIPPON PHARMA CO LTD (JP) | 2016-02-03 | — | — | EP | claimed |
| US-8012964-B2 | 9-substituted 8-oxoadenine compound | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2011-09-06 | — | — | US | disclosed |
| US-20110046369-A1 | METHOD FOR PREPARING ADENINE COMPOUND | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2011-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046369-A1 | METHOD FOR PREPARING ADENINE COMPOUND | AMPD2, APRT, PARP2 | TLR7 368/4885IL6 2043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.